Funding

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Funder
National Institutes of Health
Programme
PAR-25-104
Opportunity type
Research funding opportunity
Call status
Closed
Opens
2025-01-25
Deadline
2026-10-26
View opportunity

Overview

Supports planning and feasibility research for cancer prevention and control clinical trials. Projects should resolve practical or scientific uncertainties needed to finalise a future trial, with an optional pilot clinical trial.

Funding amount

Up to USD 450,000 in direct costs over 3 years, or USD 600,000 with a pilot trial; maximum USD 225,000 per year

Eligibility

Wits may apply as a non-US higher education institution. Proposals must fit this call and the mission of a participating institute; institutional registrations and funder requirements apply.

Additional deadlines

Next application deadline, including permitted resubmissions: 26 October 2026. The listed 25 October 2026 date falls on a weekend; NIH extends it to the next business day. Submit by 17:00 local time of the applicant organisation. Call expiration: 26 October 2027. This is separate from the application deadline.

Official source
NIH / Grants.gov
Last checked
2026-09-19